DNA methylation aging clocks: challenges and recommendations
Abstract
Epigenetic clocks comprise a set of CpG sites whose DNA methylation levels measure subject age. These clocks are acknowledged as a highly accurate molecular correlate of chronological age in humans and other vertebrates. Also, extensive research is aimed at their potential to quantify biological aging rates and test longevity or rejuvenating interventions. Here, we discuss key challenges to understand clock mechanisms and biomarker utility. This requires dissecting the drivers and regulators of age-related changes in single-cell, tissue- and disease-specific models, as well as exploring other epigenomic marks, longitudinal and diverse population studies, and non-human models. We also highlight important ethical issues in forensic age determination and predicting the trajectory of biological aging in an individual.
MeSH terms
Funding
- National Science Foundation
- American Association for Cancer Research
- Joint Programming Initiative A healthy diet for a healthy life
- Cancer Research UK
- National Institute for Health and Care Research
- Department of Health and Social Care
- Diabetes UK
- University of Bristol
- Deutsche Forschungsgemeinschaft
- National Natural Science Foundation of China
- ZonMw
- Alzheimer’s Research UK
- Bundesministerium für Bildung und Forschung
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Deutsche Krebshilfe
- RWTH Aachen University
- University College London Hospitals NHS Foundation Trust
- National Institutes of Health
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Economic and Social Research Council
- UCLH Biomedical Research Centre
- National Institute on Aging
- National Cancer Institute
- National Institute of Environmental Health Sciences
- Institute of Genetics
How this paper connects to the literature. Drag to explore, click any node to open that paper.
